Monoclonal Antibodies The approach (s), which is/are currently followed to produce human monoclonal antibodies, is/are known as transformation of antigen specific B lymphocytes (EBV) combination of EB Vand hybridoma techniques hybridization of 6-thioguanine-resistant human plasmacytoma with immune human lymphocytes all of these transformation of antigen specific B lymphocytes (EBV) combination of EB Vand hybridoma techniques hybridization of 6-thioguanine-resistant human plasmacytoma with immune human lymphocytes all of these ANSWER DOWNLOAD EXAMIANS APP
Monoclonal Antibodies Some cross reactions with monoclonal antibodies (MAbs) can occur. Unexpected cross reactions occur more frequently with IgG IgA IgE Ig MAbs IgG IgA IgE Ig MAbs ANSWER DOWNLOAD EXAMIANS APP
Monoclonal Antibodies Preliminary clinical results with a humanized antibody against the interleukin-2 receptor have suggested the All of these poor recognition of immunoglobulin, Ig constant regions absence of human immune response against murine proteins (HAMA) response presence of HAMA response All of these poor recognition of immunoglobulin, Ig constant regions absence of human immune response against murine proteins (HAMA) response presence of HAMA response ANSWER DOWNLOAD EXAMIANS APP
Monoclonal Antibodies The cross linkage of antigens by antibodies is known as complement fixation all of these a cross reaction agglutination complement fixation all of these a cross reaction agglutination ANSWER DOWNLOAD EXAMIANS APP
Monoclonal Antibodies In monoclonal antibody technology, tumor cells that can replicate endlessly are fused with mammalian cells that produce an antibody. The result of this cell fusion is a lymphoblast myeloma natural killer cell hybridoma lymphoblast myeloma natural killer cell hybridoma ANSWER DOWNLOAD EXAMIANS APP